Kirkland, Wash.-based Cardiac Insight is still seeking $5.5 million in a round of C-1 financing that recently generated $4.5 million to support sales, marketing and distribution of its Cardea Solo 7-day ECG sensor. The company also created a scientific advisory board, appointing former Heart Rhythm Society President Robert Hauser as chair, and also tapped OncoResponse CEO Clifford Stocks to serve on its board of directors.
Cardiac Insight eyes $5.5M in additional funding, announces leadership changes
Sign up for AdvaMed SmartBrief
A daily brief designed specifically for diagnostic product and health information executives.
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.